Enlivex Therapeutics Ltd.

For profitWebsite ↗

Also known as: Enlivex Therapeutics Ltd. | Enlivex Therapeutics LTD Email:mevorachd@gmail.com | Enlivex Therapeutics R&D | Enlivex Therapeutics RDO Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Jan 27, 2019

Last known activity

Aug 31, 2024

Timeline

2000s

Jan 1, 2005
Enlivex Therapeutics Ltd.— Founded

Drugs by trial phase (3 distinct, 9 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

ringer's lactate

Indications

Studied for

Recent trials (12)

NCT06522035Lead sponsorPhase 1Aug 31, 2024
NCT06233474Lead sponsorPhase 1/Phase 2Jan 26, 2024
NCT06208241CollaboratorEarly Phase 1Jul 12, 2023
NCT05581719Lead sponsorPhase 1/Phase 2Oct 31, 2022
NCT05431907Lead sponsorPhase 1/Phase 2Jun 29, 2022
NCT04922957Lead sponsorPhase 2Sep 30, 2021
NCT04922957Study directorPhase 2Sep 30, 2021
NCT04659304Study directorPhase 1Mar 31, 2021
NCT04659304Lead sponsorPhase 1Mar 31, 2021
NCT04612413Lead sponsorPhase 2Nov 15, 2020
NCT03925857Lead sponsorPhase 1Jan 27, 2019
NCT03925857Study directorPhase 1Jan 27, 2019

Details

Founded: Ness Ziona, IL Jan 1, 2005
Last known activity: Aug 31, 2024